Invention Grant
- Patent Title: MECP2E1 gene
-
Application No.: US15914770Application Date: 2018-03-07
-
Publication No.: US10577657B2Publication Date: 2020-03-03
- Inventor: Berge A. Minassian , John B. Vincent
- Applicant: The Hospital For Sick Children , Centre for Addiction and Mental Health
- Applicant Address: CA Toronto CA Toronto
- Assignee: The Hospital For Sick Children,Centre for Addiction and Mental Health
- Current Assignee: The Hospital For Sick Children,Centre for Addiction and Mental Health
- Current Assignee Address: CA Toronto CA Toronto
- Agency: Foley & Lardner LLP
- Main IPC: A61K47/26
- IPC: A61K47/26 ; C12Q1/6883 ; C07K14/47 ; G01N33/68 ; A61K38/17 ; A61K38/00 ; A61K48/00
Abstract:
The invention is a novel MECP2E1 splice variant and its corresponding polypeptide. The invention also includes methods of using these nucleic acid sequences and proteins in medical diagnosis and treatment of neuropsychiatric disorders or development disorders.
Public/Granted literature
- US20180265926A1 MECP2E1 GENE Public/Granted day:2018-09-20
Information query
IPC分类:
